Trinity's Tony Teramana Cancer Center — Steubenville, Ohio

Trinity's Tony Teramana Cancer Center is a clinical research site located in Steubenville, Ohio, United States 43952.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Trinity's Tony Teramana Cancer Center has participated in 44 clinical trials with 29 currently active.

Therapeutic areas: Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma.

Sponsors: Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Steubenville

Browse all research sites in Ohio · View every site in Steubenville

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trinity's Tony Teramana Cancer Center?

Trinity's Tony Teramana Cancer Center has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trinity's Tony Teramana Cancer Center conducted?

Trinity's Tony Teramana Cancer Center has 44 clinical trials on record, with 29 currently active. Their work covers Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma.

Is Trinity's Tony Teramana Cancer Center accredited by Crixeo Clinical Trials?

Trinity's Tony Teramana Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trinity's Tony Teramana Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.